News News Select Year All Years 2026 (17) 2025 (34) 2024 (29) 2023 (30) 2022 (33) 2021 (27) 2020 (34) 2019 (32) 2018 (42) 2017 (35) 2016 (43) 2015 (53) 2014 (26) 2013 (21) 2012 (16) 2011 (6) 2010 (4) 2009 (5) 2007 (1) 2006 (1) Search News Found 489 Results Page 33 of 49« First«...1020...3132333435...40...»Last » September 21, 2016 DBV Technologies Receives FDA Fast Track Designation for Viaskin Milk for the Treatment of Cow’s Milk Protein Allergy September 6, 2016 DBV Technologies, BioNet-Asia and the Geneva University Hospitals Initiate Phase I Study of Viaskin rPT for Pertussis Booster Vaccination September 1, 2016 DBV Technologies to Attend Upcoming Investor Conferences August 1, 2016 DBV Technologies Announces Expansion of Clinical Program of Viaskin Peanut for the Treatment of Peanut Allergy July 28, 2016 First Half of 2016 Condensed Consolidated Financial Statements July 28, 2016 DBV Technologies Reports Interim Financial Results for the First Half of 2016 July 11, 2016 Half year update on the DBV Technologies liquidity agreement July 5, 2016 DBV Technologies Proudly Welcomes Dr. Lucia Septién as Chief Medical Officer June 27, 2016 DBV Technologies Announces Completion of Recruitment in Global Phase III Study of Viaskin Peanut for the Treatment of Peanut Allergic Children June 21, 2016 DBV Announced Results of its 2016 Annual Meeting of Shareholders Page 33 of 49« First«...1020...3132333435...40...»Last »
